Zevra Therapeutics, Inc. (ZVRA)
Total Valuation
ZVRA has a market cap or net worth of $232.76 million. The enterprise value is $152.16 million.
Market Cap | 232.76M |
Enterprise Value | 152.16M |
Important Dates
The next confirmed earnings date is Thursday, March 28, 2024, after market close.
Earnings Date | Mar 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 41.49 million shares outstanding. The number of shares has increased by 0.67% in one year.
Shares Outstanding | 41.49M |
Shares Change (YoY) | +0.67% |
Shares Change (QoQ) | +2.44% |
Owned by Insiders (%) | 8.02% |
Owned by Institutions (%) | 31.12% |
Float | 31.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 14.05 |
Forward PS | 8.36 |
PB Ratio | 3.45 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 9.19 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.66.
Current Ratio | 6.31 |
Quick Ratio | 6.23 |
Debt / Equity | 0.66 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -51.36 |
Financial Efficiency
Return on equity (ROE) is -54.50% and return on invested capital (ROIC) is -39.35%.
Return on Equity (ROE) | -54.50% |
Return on Assets (ROA) | -34.20% |
Return on Capital (ROIC) | -39.35% |
Revenue Per Employee | $517,594 |
Profits Per Employee | -$1.25M |
Employee Count | 32 |
Asset Turnover | 0.14 |
Inventory Turnover | 2.02 |
Taxes
Income Tax | -34,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.91% in the last 52 weeks. The beta is 1.82, so ZVRA's price volatility has been higher than the market average.
Beta (1Y) | 1.82 |
52-Week Price Change | +10.91% |
50-Day Moving Average | 6.16 |
200-Day Moving Average | 5.28 |
Relative Strength Index (RSI) | 47.94 |
Average Volume (30 Days) | 260,119 |
Short Selling Information
The latest short interest is 2.13 million, so 5.14% of the outstanding shares have been sold short.
Short Interest | 2.13M |
Short Previous Month | 2.15M |
Short % of Shares Out | 5.14% |
Short % of Float | 6.84% |
Short Ratio (days to cover) | 8.96 |
Income Statement
In the last 12 months, ZVRA had revenue of $16.56 million and -$39.92 million in losses. Loss per share was -$1.15.
Revenue | 16.56M |
Gross Profit | 15.47M |
Operating Income | -44.19M |
Pretax Income | -39.95M |
Net Income | -39.92M |
EBITDA | -38.67M |
EBIT | -39.19M |
Loss Per Share | -$1.15 |
Balance Sheet
The company has $125.43 million in cash and $44.82 million in debt, giving a net cash position of $80.60 million or $1.94 per share.
Cash & Cash Equivalents | 125.43M |
Total Debt | 44.82M |
Net Cash | 80.60M |
Net Cash Per Share | $1.94 |
Equity / Book Value | 67.47M |
Book Value Per Share | 1.63 |
Working Capital | 115.30M |
Cash Flow
In the last 12 months, operating cash flow was -$21.84 million and capital expenditures -$258,000, giving a free cash flow of -$22.10 million.
Operating Cash Flow | -21.84M |
Capital Expenditures | -258,000 |
Free Cash Flow | -22.10M |
FCF Per Share | -$0.64 |
Margins
Gross margin is 93.43%, with operating and profit margins of -266.78% and -241.00%.
Gross Margin | 93.43% |
Operating Margin | -266.78% |
Pretax Margin | -241.21% |
Profit Margin | -241.00% |
EBITDA Margin | -233.47% |
EBIT Margin | -236.60% |
FCF Margin | -133.41% |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.67% |
Shareholder Yield | -0.67% |
Earnings Yield | -17.15% |
FCF Yield | -9.49% |
Analyst Forecast
The average price target for ZVRA is $20.00, which is 245.42% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.00 |
Price Target Difference | 245.42% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 75.72% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
Last Split Date | Dec 28, 2020 |
Split Type | Reverse |
Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of -1.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.28 |
Piotroski F-Score | 2 |